tiprankstipranks

Analyst Profile

Followed by 179 followers
.
Michelle Gilson

Michelle Gilson

Canaccord Genuity
Wall Street Analyst
#1,622 out of 7,986 Wall Street Analysts
#3,183 out of 22,378 experts

Success Rate

42%
60 out of 143 transactions made a profit

Average Return

+7.10%
Average return per transaction
Time Frame
1 Year
Compare to
No Benchmark
Copying Michelle Gilson's trades since 2016 and holding each position for 1 Year would result in 41.96% of your transactions generating a profit, with an average return of 7.1% per rating.

Stock Rating Distribution

187Ratings
98.93% Buy
1.07% Hold
0.00% Sell
Distribution of Michelle Gilson's ratings

Additional Information

Main Sector:Healthcare
Geo Coverage:
United StatesUS Market

Best Rating

Stock:
ChemoCentryx Inc
(CCXI)
Rating:Buy
Date:Nov 25, 2019 - Nov 25, 2020
Return:+569.90%
The most profitable rating made by Michelle Gilson

Michelle Gilson's Stock Coverage

Company
Date
Position
Action
Price Target
No. of Ratings
Success Rate
Avg. Return
Vertex Pharmaceuticals
Jul 13, 2016
Hold
Assigned
1Ratings
0.00%
XLRN
Acceleron Pharma
Jul 13, 2016
Buy
Assigned
1Ratings
0%
-3.40%
uniQure
Jul 27, 2016
Buy
Reiterated
$23.00
(13.81% Upside)
1Ratings
100%
+11.30%
Pieris Pharmaceuticals
Aug 11, 2016
Buy
Reiterated
$10.00
(777.19% Upside)
1Ratings
100%
+171.00%
Cellectis SA
Sep 13, 2016
Buy
Reiterated
$65.00
(2619.67% Upside)
1Ratings
100%
+10.30%
Synlogic
Sep 20, 2016
Hold
Downgraded
2Ratings
0%
-38.80%
Summit Therapeutics
Oct 06, 2016
Buy
Reiterated
$28.00
(2468.81% Upside)
3Ratings
67%
+72.27%
Sarepta Therapeutics
Oct 31, 2016
Buy
Reiterated
$76.00
(-33.81% Downside)
8Ratings
75%
+68.65%
Affimed
Nov 02, 2016
Buy
Reiterated
$19.00
(869.39% Upside)
1Ratings
0%
-2.30%
Kura Oncology
Nov 07, 2016
Buy
Reiterated
$16.00
(8.70% Upside)
2Ratings
100%
+139.80%
List of latest recommendations made by Michelle Gilson. Click to expand and see Michelle Gilson's performance on a particular stock
Disclaimer: TipRanks collects analysts’ ratings and price targets by scanning publicly available reports on financial websites and by receiving reports from analysts, firms, or customers. The information and statistics displayed might not be accurate, complete, or up-to-date. The analyst ratings provided are the sole responsibility of the source publication. TipRanks holds no liability over the analysts' information, price targets, ratings, or opinions expressed.
Send Us Reports
If you receive reports that you think we are missing, we will thank you with a free Ultimate upgrade!
Learn More >